menu
    • menu
    [{"orgOrder":0,"company":"Cognision","sponsor":"Kynexis Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2025","type":"Partnership","leadProduct":"KYN-5356","moa":"KAT2","graph1":"Undisclosed","graph2":"Approved FDF","graph3":"Cognision","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Cognision \/ Kynexis Therapeutics","highestDevelopmentStatusID":"15","companyTruncated":"Cognision \/ Kynexis Therapeutics"}]

    Find Clinical Drug Pipeline Developments & Deals by Cognision

    Menu

    Cognision

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Cognision

                            U.S.A arrow
                            CPhI India
                            Not Confirmed

                            Cognision

                            U.S.A arrow
                            CPhI India
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : KYN-5356

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Kynexis Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Cognision Partners with Kynexis for Phase 2 Trial of KYN-5356 in Schizophrenia Subjects

                            Details : The partnership with KYN-5356 aims to advance the treatment of neurological disorders by targeting KAT2.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Undisclosed

                            November 14, 2025

                            Lead Product(s) : KYN-5356

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Kynexis Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth